Cubist Systematic Strategies’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $538K | Buy |
+55,723
| New | +$493K | ﹤0.01% | 2244 |
|
|
2025
Q2 | – | Sell |
-357,792
| Closed | -$2.56M | – | 3430 |
|
|
2025
Q1 | $2.56M | Sell |
357,792
-3,521
| -1% | -$26.2K | 0.02% | 1276 |
|
|
2024
Q4 | $2.79M | Buy |
+361,313
| New | +$3.39M | 0.02% | 1166 |
|
|
2024
Q3 | – | Sell |
-188,235
| Closed | -$2.2M | – | 3415 |
|
|
2024
Q2 | $2.2M | Buy |
188,235
+79,655
| +73% | +$1.24M | 0.02% | 1268 |
|
|
2024
Q1 | $2.29M | Buy |
108,580
+74,313
| +217% | +$1.32M | 0.01% | 1540 |
|
|
2023
Q4 | $615K | Sell |
34,267
-36,918
| -52% | -$650K | ﹤0.01% | 2412 |
|
|
2023
Q3 | $1.17M | Sell |
71,185
-26,074
| -27% | -$473K | 0.01% | 1765 |
|
|
2023
Q2 | $1.94M | Buy |
+97,259
| New | +$1.87M | 0.01% | 1505 |
|
|
2023
Q1 | – | Sell |
-29,032
| Closed | -$658K | – | 4333 |
|
|
2022
Q4 | $658K | Sell |
29,032
-4,810
| -14% | -$109K | ﹤0.01% | 2826 |
|
|
2022
Q3 | $894K | Buy |
33,842
+14,811
| +78% | +$439K | 0.01% | 2714 |
|
|
2022
Q2 | $470K | Sell |
19,031
-70,192
| -79% | -$1.75M | ﹤0.01% | 3108 |
|
|
2022
Q1 | $2.96M | Buy |
89,223
+79,823
| +849% | +$2.22M | 0.03% | 1164 |
|
|
2021
Q4 | $307K | Sell |
9,400
-58,454
| -86% | -$1.99M | ﹤0.01% | 2779 |
|
|
2021
Q3 | $2.84M | Buy |
67,854
+54,135
| +395% | +$1.95M | 0.04% | 787 |
|
|
2021
Q2 | $533K | Sell |
13,719
-7,573
| -36% | -$271K | 0.01% | 1965 |
|
|
2021
Q1 | $726K | Buy |
21,292
+19,738
| +1,270% | +$842K | 0.01% | 1746 |
|
|
2020
Q4 | $70K | Sell |
1,554
-18,869
| -92% | -$659K | ﹤0.01% | 2441 |
|
|
2020
Q3 | $562K | Buy |
20,423
+10,682
| +110% | +$348K | 0.01% | 1681 |
|
|
2020
Q2 | $359K | Buy |
+9,741
| New | +$363K | 0.01% | 1764 |
|
|
2020
Q1 | – | Sell |
-53,005
| Closed | -$2.17M | – | 2399 |
|
|
2019
Q4 | $2.17M | Buy |
+53,005
| New | +$2.09M | 0.04% | 706 |
|
|
2019
Q3 | – | Sell |
-29,925
| Closed | -$1.54M | – | 2424 |
|
|
2019
Q2 | $1.54M | Buy |
+29,925
| New | +$1.49M | 0.03% | 809 |
|
|
2019
Q1 | – | Sell |
-10,844
| Closed | -$455K | – | 2394 |
|
|
2018
Q4 | $455K | Buy |
+10,844
| New | +$636K | 0.02% | 1025 |
|
|
2018
Q3 | – | Sell |
-4,163
| Closed | -$299K | – | 2046 |
|
|
2018
Q2 | $299K | Sell |
4,163
-3,908
| -48% | -$187K | 0.02% | 1089 |
|
|
2018
Q1 | $241K | Buy |
+8,071
| New | +$235K | 0.01% | 1285 |
|
|
2017
Q2 | – | Sell |
-815
| Closed | -$16K | – | 1849 |
|
|
2017
Q1 | $16K | Buy |
+815
| New | +$15.7K | ﹤0.01% | 1556 |
|
Other funds holding RGNX
RG
Cubist Systematic Strategies's RGNX Position: Q3 2025 in Review
Cubist Systematic Strategies opened a new position in Regenxbio (RGNX) in Q3 2025: 55,723 shares worth $538K. The stake represents ﹤0.01% of the portfolio and ranks #2244 among its holdings. This is a return to the name: Cubist Systematic Strategies previously reported a position in RGNX as recently as Q1 2025.
Cubist Systematic Strategies first reported a position in RGNX in Q1 2017 and has held it in 25 quarters since. The position peaked at $2.96M in Q1 2022. 166 funds tracked by Wall St. Rank hold RGNX as of Q3 2025.
- Cubist Systematic Strategies held 55,723 shares of Regenxbio worth $538K as of Q3 2025.
- Regenxbio was a new Cubist Systematic Strategies position in Q3 2025.
- Regenxbio made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2244 holding.
- Cubist Systematic Strategies first reported a position in Regenxbio in Q1 2017 and has held it in 25 quarters since.
- Cubist Systematic Strategies's Regenxbio position peaked at $2.96M in Q1 2022.
- 166 funds tracked by Wall St. Rank held Regenxbio as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.